David M. Reese, M.D.
CTO
Amgen Inc (AMGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David M. Reese, M.D.
David M. Reese, M.D. is recorded as CTO at Amgen Inc (AMGN). Amgen Inc reported in an 8-K filed April 22, 2026 that David M. Reese, M.D. retired as Executive Vice President, effective June 30, 2026. Amgen Inc reported in an 8-K filed April 22, 2026 that David M. Reese, M.D. retired as Executive Vice President and Chief Technology Officer, effective June 30, 2026. Amgen Inc reported in an 8-K filed December 14, 2023 that David M. Reese, M.D. was appointed Executive Vice President and Chief Technology Officer, effective December 18, 2023. The proxy statement of Amgen Inc reports total compensation of $8,126,822 for David M. Reese, M.D. in fiscal 2024, including a base salary of $1,268,615. Disclosed compensation is on record for 3 fiscal years.
“On June 30, 2026, Dr. Reese will retire from the role of Executive Vice President.”
“On April 22, 2026, Amgen Inc. (the "Company") publicly announced that David M. Reese is retiring from the role of the Company's Executive Vice President and Chief Technology Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-12-18–present
-
2023-12-18–2026-06-30
-
Amgen Inc (AMGN)
Proxy statement
Start not stated–2026-06-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Amgen Inc
Other people whose current roles at this company are on record from its filings.
- Robert Bradway CEO
- David W. Meline CFO
- Thomas Dittrich CFO
- Sean Bruich CTO
- Jonathan P. Graham General Counsel
- Linda H. Louie Chief Accounting Officer
- Matthew C. Busch Chief Accounting Officer
- Amy E. Miles Board Member
- Michael V. Drake Board Member
- S. Omar Ishrak Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Amgen Inc (AMGN) | Executive Vice President, and Chief Technology Officer | $1,268,615 | $8,126,822 |
| 2023 | Amgen Inc (AMGN) | Executive Vice President, and Chief Technology Officer | $1,212,823 | $7,902,655 |
| 2022 | Amgen Inc (AMGN) | Executive Vice President, and Chief Technology Officer | $1,158,846 | $7,333,124 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.